DE602006017882D1 - Zusammensetzungen und verfahren zur erhöhung der produktion rekombinanter gamma-carboxylierter proteine - Google Patents

Zusammensetzungen und verfahren zur erhöhung der produktion rekombinanter gamma-carboxylierter proteine

Info

Publication number
DE602006017882D1
DE602006017882D1 DE602006017882T DE602006017882T DE602006017882D1 DE 602006017882 D1 DE602006017882 D1 DE 602006017882D1 DE 602006017882 T DE602006017882 T DE 602006017882T DE 602006017882 T DE602006017882 T DE 602006017882T DE 602006017882 D1 DE602006017882 D1 DE 602006017882D1
Authority
DE
Germany
Prior art keywords
methods
compositions
increasing
production
carboxylated proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006017882T
Other languages
English (en)
Inventor
Reidar Wallin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wake Forest University Health Sciences
Original Assignee
Wake Forest University Health Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wake Forest University Health Sciences filed Critical Wake Forest University Health Sciences
Publication of DE602006017882D1 publication Critical patent/DE602006017882D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6437Coagulation factor VIIa (3.4.21.21)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6432Coagulation factor Xa (3.4.21.6)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE602006017882T 2005-12-02 2006-12-04 Zusammensetzungen und verfahren zur erhöhung der produktion rekombinanter gamma-carboxylierter proteine Active DE602006017882D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74207605P 2005-12-02 2005-12-02
US78205606P 2006-03-14 2006-03-14
PCT/US2006/061575 WO2007065173A2 (en) 2005-12-02 2006-12-04 Compositions and methods for increasing production of recombinant gamma-carboxylated proteins

Publications (1)

Publication Number Publication Date
DE602006017882D1 true DE602006017882D1 (de) 2010-12-09

Family

ID=38092974

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006017882T Active DE602006017882D1 (de) 2005-12-02 2006-12-04 Zusammensetzungen und verfahren zur erhöhung der produktion rekombinanter gamma-carboxylierter proteine

Country Status (7)

Country Link
US (2) US8647868B2 (de)
EP (1) EP1963506B1 (de)
AT (1) ATE486128T1 (de)
AU (1) AU2006320168B2 (de)
CA (1) CA2632794C (de)
DE (1) DE602006017882D1 (de)
WO (1) WO2007065173A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1842920T5 (pl) 2003-09-23 2018-04-30 University Of North Carolina At Chapel Hill Komórki koekspresjonujące reduktazę witaminy K i białko zależne od witaminy K oraz ich zastosowanie do poprawienia wydajności wytwarzania tego białka zależnego od witaminy K
GB0324044D0 (en) 2003-10-14 2003-11-19 Astrazeneca Ab Protein
PT1673450E (pt) 2003-10-14 2010-05-11 Baxter Int Polipéptido de reciclagem de epóxido de vitamina k, vkorc1, um alvo terapêutico de cumarina e seus derivados
AU2005329450A1 (en) 2005-03-15 2006-09-28 University Of North Carolina At Chapel Hill Methods and compositions for producing active Vitamin K-dependent proteins
NZ561925A (en) 2005-04-13 2010-04-30 Astrazeneca Ab A host cell comprising a vector for production of proteins requiring gamma-carboxylation
US8206967B2 (en) 2007-07-06 2012-06-26 Medimmune Limited Method for production of recombinant human thrombin
JP5781067B2 (ja) 2009-07-10 2015-09-16 シーエスエル、リミテッド ビタミンk依存性タンパク質の発現収率を増加させる方法
WO2011086197A1 (en) 2010-01-18 2011-07-21 Novo Nordisk Health Care Ag Purification of blood coagulation factors
EP2655607A4 (de) 2010-12-21 2014-05-14 Univ North Carolina Verfahren und zusammensetzungen zur herstellung aktiver vitamin-k-abhängiger proteine
EP3305810A4 (de) * 2015-05-27 2018-04-25 Fundacao Hemocentro de Ribeirao Preto Verfahren zur herstellung von blutgerinnungsfaktor vii sowie blutgerinnungsfaktor vii
BR102015012334A2 (pt) 2015-05-27 2016-11-29 Fundação Hemoct De Ribeirão Preto Fundherp processo de produção do fator vii de coagulação sanguínea e fator vii de coagulação sanguínea

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003276430A1 (en) * 2002-06-14 2003-12-31 Stowers Institute For Medical Research Wise/sost nucleic acid sequences and amino acid sequences
WO2005080585A1 (en) * 2004-02-13 2005-09-01 Glycotope Gmbh Highly active glycoproteins-process conditions and an efficient method for their production
US20060073117A1 (en) * 2004-10-01 2006-04-06 Stowers Institute For Medical Research Methods and compositions for controlling hair follicle stem cell fate
EP1819832A2 (de) * 2004-11-23 2007-08-22 K.U.Leuven Research & Development Autismusgene und regulierte sekretion
EP1831363A1 (de) * 2004-12-21 2007-09-12 Novo Nordisk Health Care AG Expression von gamma-carboxylierten polypeptiden in wirtssystemen mit gamma-carboxylierungsmangel
EP2295547B1 (de) * 2005-02-28 2017-09-20 Baxalta GmbH Rekombinante co-Expression der Vitamin-K-Epoxide-Reduktase-Untereinheit 1 zur Verbesserung der Expression Vitamin-K-abhängiger Proteine
NZ561925A (en) 2005-04-13 2010-04-30 Astrazeneca Ab A host cell comprising a vector for production of proteins requiring gamma-carboxylation

Also Published As

Publication number Publication date
AU2006320168A1 (en) 2007-06-07
WO2007065173A3 (en) 2008-07-03
EP1963506A2 (de) 2008-09-03
ATE486128T1 (de) 2010-11-15
CA2632794C (en) 2015-04-07
CA2632794A1 (en) 2007-06-07
US20140227248A1 (en) 2014-08-14
US8647868B2 (en) 2014-02-11
EP1963506B1 (de) 2010-10-27
AU2006320168B2 (en) 2012-02-23
US20100331255A1 (en) 2010-12-30
EP1963506A4 (de) 2009-01-07
WO2007065173A2 (en) 2007-06-07

Similar Documents

Publication Publication Date Title
DE602006017882D1 (de) Zusammensetzungen und verfahren zur erhöhung der produktion rekombinanter gamma-carboxylierter proteine
NL301145I2 (nl) Tirbanibulin
IN2012DN00801A (de)
WO2011047087A3 (en) Protein detection via nanoreporters
SG10201405377XA (en) Compositions and methods for antibodies targeting complement protein c5
DE602006016735D1 (de) Verfahren zur proliferation von stammzellen
MX2009005655A (es) Composiciones y usos de un polipeptido alfa-amilasa del bacilo de la especie 195.
SG166770A1 (en) Use of adipose tissue-derived stromal stem cells in treating fistula
SG165339A1 (en) Incorporation of non-naturally encoded amino acids into proteins
MX2008001538A (es) Aril piridinas y metodos para su uso.
DK2002016T3 (da) Fremgangsmåde til bestemmelse af kopital
WO2006069719A3 (en) Lyophilization of virosomes
MY146352A (en) Adipose derived adult stem cells in hepatic regeneration
ATE501268T1 (de) Vorrichtungen und verfahren zur bestimmung von proteaseaktivität
WO2008085962A3 (en) Cell culture methods for producing recombinant proteins in the presence of reduced levels of one or more contaminants
MX341064B (es) Variantes de la familia il-1.
ATE497779T1 (de) Enzyme zur reduzierung von immunologischem stress
DE602007012412D1 (de) Rekombinante produktion heparinbindender proteine
MY162185A (en) Alumina particles and methods of making the same
MX2009012643A (es) Particulas de alumina y metodos para fabricar las mismas.
EP1885867A4 (de) Neue verfahren
TW200738752A (en) Modulation of MDL-1 activity for treatment of inflammatory disease
ATE420162T1 (de) Verfahren und zusammensetzungen zum targeting sekretorischer lysosomen
WO2010123885A3 (en) Iga1 protease polypeptide agents and uses thereof
TW200504218A (en) Methods for preventing gluconoylation of proteins